For the first six weeks the group will focus on one of two therapies, either anxiety management therapy or cognitive therapy. Following a one week break, the group will then focus for six weeks on behavior therapy. Participants are limited to those people who have OCD or immediate family members. Studies consist of a single visit, lasting between 4 and 5 hours of laboratory testing. No needles or any painful procedures are involved.
Time is set aside to discuss the outcome of the interview.
Eligible individuals must have a diagnosis of OCD, and other eligibility restriction may apply. Use of medications does not preclude study participation. Participants will receive Prozac for several months. Participants will continue to be monitored for OCD symptoms for the remainder of the 73 weeks. All participants receive medication in the first part of the study, which lasts up to 10 weeks, with visits every 2 weeks to our Institute in Great Neck, Long Island.